Just a few months after Johnson & Johnson Inc. acquired Danvers medical device maker Abiomed Inc. for a whopping $16.6 billion, the device at the heart of the acquisition — a minimally invasive heart pump — is being partially recalled.
Just a few months after Johnson & Johnson Inc. acquired Danvers medical device maker Abiomed Inc. for a whopping $16.6 billion, the device at the heart of the acquisition — a minimally invasive heart pump — is being partially recalled.
